Added to YB: 2025-01-24
Pitch date: 2025-01-24
PACB [neutral]
Pacific Biosciences of California, Inc.
-23.78%
current return
Author Info
Two Natural Capital writes about markets, particularly focused on life sciences/biotech. Sign up for the newsletter.
Company Info
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems.
Market Cap
$397.6M
Pitch Price
$1.64
Price Target
N/A
Dividend
N/A
EV/EBITDA
-6.20
P/E
-3.01
EV/Sales
5.17
Sector
Life Sciences Tools and Services
Category
N/A
Pacific Biosciences of California, Inc. - $PACB
PACB (overview): Long-read sequencing leader, improving accuracy/cost. New Revio & Vega machines. Q1 utilization low. Short-read Onso launched to compete with Illumina. Valued similarly to ILMN at 5.7x '25 rev despite negative EBITDA, 23% YoY rev decline. R&D crucial. Uncertainty on demand & short-read success.
Read full article (6 min)